3rd Quarter Results

RNS Number : 5620T
British Smaller Companies VCT PLC
20 March 2023
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2022

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2022. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com .

Overview

In the quarter to 31 December 2022 the Company generated a Total Return of 4.3 pence per ordinary share, a 5.1 per cent increase on the net asset value (NAV) at the beginning of the quarter of 85.0 pence per share. The Company is now ranked first across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5 and 10 years.  Total Return is now 257.7 pence per share.

Performance

The table below sets out movements in key metrics for the Company. 

 

 

30 September 2022

Increase in Value

Dividends paid/shares issued

Buyback of shares

Movement

In Period

31  December 2022

Net Assets (£m)

158.1

8.0

(2.8)

(0.6)

4.6

162.7

NAV per share (PPS)

85.0

4.3

(2.0)

-

2.3

87.3

Cumulative dividends paid (PPS)

168.4

-

2.0

-

2.0

170.4

Total Return (PPS)

253.4

4.3

-

-

4.3

257.7

Shares in issue

186,112,757

-

1,054,908

(775,240)

279,668

186,392,425

The unaudited NAV per ordinary share increased in value by 4.3 pence; after payment of 2.0 pence of dividends, NAV per ordinary share stood at 87.3 pence per share at the period end. Cumulative dividends paid at 31 December 2022 were 170.4 pence per ordinary share (30 September 2022: 168.4 pence per ordinary share).

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 September 2022


158.1


85.0

Increase in portfolio value

7.5


4.0


Net operating income

0.5


0.3



8.0


4.3


Issue/buy-back of shares

0.3


-


Total Return in the period


8.3


4.3

NAV before the payment of dividends


166.4


89.3

Dividends paid


(3.7)


(2.0)

NAV at 31 December 2022

 

162.7

 

87.3

 

Post-period end, on 11 January 2023, a special dividend of 4.5 pence per ordinary share for the year ending 31 March 2023 was paid, resulting in a corresponding reduction to the 31 December 2022 unaudited NAV, to 82.8 pence per ordinary share.

Net assets

Net assets at 31 December 2022 comprised the following:


£000

% of net assets

Unquoted investments at fair value

114,101

70.1

Listed investment funds

4,269

2.6

Cash and cash equivalents

42,687

26.3

Other net assets

1,599

1.0

Net assets

162,656

100.0

Investments

Over the quarter to 31 December 2022, the aggregate unquoted portfolio valuation increased by £7.5 million.  In December 2022, the Company completed the partial exit of its investment in planning and forecasting software and services business, Vuealta, through the sale of its fast-growing software division to long-standing partner, Anaplan. The sale generated proceeds of £4.6 million, 1.5x cost, and an uplift of 45 per cent, or £1.4 million, on the carrying value at the beginning of the year (including further investments made in the financial year prior to sale). The Company remains invested in the core Vuealta consulting business to support its next phase of growth.

During the quarter, the Company deployed £7.7 million into four new investments: AutomatePro (automated software testing), Biorelate (data curation software), Plandek (a software development analytics platform) and Summize (digital contracting software).

A number of investments within the portfolio are seeking to extend or accelerate their growth plans, which has resulted in further investment of £4.5 million into four portfolio companies in the period, including £2.7 million into Unbiased, to help the company's overseas expansion plans.

Subsequent to the period end, a further £3.6 million has also been invested into new investment DrDoctor, a patient engagement and communications software platform, taking the total invested so far this year to £24.2 million, following the £9.7 million invested in the full year to 31 March 2022.

 

The investment portfolio at 31 December 2022 comprised:


Valuation

£000

Cumulative valuation as a % of net assets

Matillion Limited

25,895

15.9%

Outpost VFX Limited

9,302

21.6%

Unbiased EC1 Limited

9,107

27.2%

Displayplan Holdings Limited

7,630

31.9%

Wooshii Limited

6,296

35.8%

Elucidat Ltd

6,058

39.5%

ACC Aviation Group Limited

5,340

42.8%

Force24 Ltd

4,636

45.7%

Vypr Validation Technologies Limited

3,897

48.1%

SharpCloud Software Limited

3,763

50.4%


 



81,924

50.4%

Other investments

32,177

70.1%

Total investments

114,101

70.1%

Investments made since November 2015 represented 84 per cent of the value of the unquoted portfolio at 31 December 2022.

Shares in issue

The Company issued 1,054,908 ordinary shares under the Company's Dividend Re-investment Scheme (DRIS) following the payment of the interim dividend on 3 October 2022.

Under its standing buyback authority, on 16 December 2022 the Company purchased 775,240 shares at 75.08 pence at a cost of £0.58 million. These shares are held in treasury. 

Subsequent to the quarter end, on 11 January 2023 the Company issued 2,507,454 shares under the DRIS following the payment of a special dividend, taking the number of shares in issue at that date to 188,899,879, with a further 20,787,165 shares held in treasury.

Fundraising

On 30 November 2022, the Company announced a new share offer, alongside British Smaller Companies VCT2 plc, with the intention of raising up to £75 million in aggregate, which included an over-allotment facility of £25 million. Gross Applications exceeding £62.5 million have been received as at the date of this report, of which £39 million relate to the Company. The related allotment will take place in early April 2023.

Outlook

The positive performance of the portfolio in the quarter is pleasing in what remains a tough economic environment.  Portfolio companies continue to show great resilience, with key investments demonstrating robust revenue growth.

We thank both existing and new shareholders for their support of the Company's current fundraising.  We are continuing to see promising new investment prospects, as well as opportunities to deploy funds into the existing portfolio to help them accelerate their growth plans.  We look forward to updating investors on our progress in investing the funds raised in the coming quarters.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

20 March 2023

For further information please contact:

David Hall   YFM Private Equity Limited    Tel:  0113 244 1000

Alex Collins   Panmure Gordon (UK) Limited   Tel:  0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTEALDEADADEFA
UK 100

Latest directors dealings